Loomis, Sayles & Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95M | Buy |
28,841
+28,155
| +4,104% | +$7.76M | 0.01% | 400 |
|
|
2025
Q1 | $182K | Buy |
686
+293
| +75% | +$77.7K | ﹤0.01% | 533 |
|
|
2024
Q4 | $91K | Sell |
393
-91
| -19% | -$21.1K | ﹤0.01% | 569 |
|
|
2024
Q3 | $107K | Buy |
484
+39
| +9% | +$8.62K | ﹤0.01% | 541 |
|
|
2024
Q2 | $87K | Buy |
445
+23
| +5% | +$4.5K | ﹤0.01% | 559 |
|
|
2024
Q1 | $91K | Sell |
422
-64
| -13% | -$13.8K | ﹤0.01% | 554 |
|
|
2023
Q4 | $102K | Buy |
486
+46
| +10% | +$9.65K | ﹤0.01% | 531 |
|
|
2023
Q3 | $88K | Buy |
440
+37
| +9% | +$7.4K | ﹤0.01% | 537 |
|
|
2023
Q2 | $75K | Sell |
403
-139
| -26% | -$25.9K | ﹤0.01% | 559 |
|
|
2023
Q1 | $104K | Buy |
542
+106
| +24% | +$20.3K | ﹤0.01% | 535 |
|
|
2022
Q4 | $73K | Sell |
436
-50
| -10% | -$8.37K | ﹤0.01% | 568 |
|
|
2022
Q3 | $86K | Buy |
+486
| New | +$86K | ﹤0.01% | 529 |
|
|
2022
Q2 | – | Sell |
-9
| Closed | -$2K | – | 986 |
|
|
2022
Q1 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 928 |
|
|
2020
Q3 | – | Sell |
-4,561
| Closed | -$741K | – | 668 |
|
|
2020
Q2 | $741K | Buy |
4,561
+4,418
| +3,090% | +$718K | ﹤0.01% | 473 |
|
|
2020
Q1 | $25K | Sell |
143
-215
| -60% | -$37.6K | ﹤0.01% | 571 |
|
|
2019
Q4 | $72K | Sell |
358
-150
| -30% | -$30.2K | ﹤0.01% | 649 |
|
|
2019
Q3 | $107K | Buy |
+508
| New | +$107K | ﹤0.01% | 550 |
|
|
2016
Q1 | – | Sell |
-8,654
| Closed | -$784K | – | 1065 |
|
|
2015
Q4 | $784K | Hold |
8,654
| – | – | ﹤0.01% | 599 |
|
|
2015
Q3 | $803K | Buy |
+8,654
| New | +$803K | ﹤0.01% | 570 |
|